학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 173건 | 목록 1~10
Academic Journal
Schendel DJ; Medigene Immunotherapies GmbH, Planegg, Germany.; Medigene AG, Planegg, Germany.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Academic Journal
Fløisand Y; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. yfl70@me.com.; Remberger M; Department of Hematology, Oslo University Hospital, Oslo, Norway.; Clinical Research and Development Unit, Uppsala University Hospital, Uppsala, Sweden.; Bigalke I; Department of Cellular Therapy, Oslo University Hospital, Oslo, Norway.; Josefsen D; Department of Cellular Therapy, Oslo University Hospital, Oslo, Norway.; Vålerhaugen H; Department of Pathology, Oslo University Hospital, Oslo, Norway.; Inderberg EM; Department of Cellular Therapy, Oslo University Hospital, Oslo, Norway.; Olaussen RW; Department of Cellular Therapy, Oslo University Hospital, Oslo, Norway.; Gjertsen BT; Department of Clinical Science, University of Bergen; Department of Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway.; Goedkoop R; Medigene Immunotherapies GmbH and Medigene AG, Martinsried, Germany.; Geiger C; Medigene Immunotherapies GmbH and Medigene AG, Martinsried, Germany.; Prinz PU; Medigene Immunotherapies GmbH and Medigene AG, Martinsried, Germany.; Schnorfeil FM; Medigene Immunotherapies GmbH and Medigene AG, Martinsried, Germany.; Bavarian Nordic GmbH, Martinsried, Germany.; Pinkernell K; Medigene Immunotherapies GmbH and Medigene AG, Martinsried, Germany.; Dr. Falk Pharma, Freiburg, Germany.; Schendel DJ; Medigene Immunotherapies GmbH and Medigene AG, Martinsried, Germany.; Kvalheim G; Department of Cellular Therapy, Oslo University Hospital, Oslo, Norway.
Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Academic Journal
Sailer N; Medigene Immunotherapies GmbH, 82152 Planegg, Germany.; Fetzer I; Medigene Immunotherapies GmbH, 82152 Planegg, Germany.; Salvermoser M; Medigene Immunotherapies GmbH, 82152 Planegg, Germany.; Braun M; Medigene Immunotherapies GmbH, 82152 Planegg, Germany.; Brechtefeld D; Medigene Immunotherapies GmbH, 82152 Planegg, Germany.; Krendl C; Medigene Immunotherapies GmbH, 82152 Planegg, Germany.; Geiger C; Medigene Immunotherapies GmbH, 82152 Planegg, Germany.; Mutze K; Medigene Immunotherapies GmbH, 82152 Planegg, Germany.; Noessner E; Immunoanalytics-Research Group Tissue Control of Immunocytes (TCI), Helmholtz Zentrum München, 81377 Munich, Germany.; Schendel DJ; Medigene Immunotherapies GmbH, 82152 Planegg, Germany.; Medigene AG, 82152 Planegg, Germany.; Bürdek M; Medigene Immunotherapies GmbH, 82152 Planegg, Germany.; Wilde S; Medigene Immunotherapies GmbH, 82152 Planegg, Germany.; Sommermeyer D; Medigene Immunotherapies GmbH, 82152 Planegg, Germany.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Academic Journal
Tryggestad AMA; Department of Oncology, Oslo University Hospital HF, Oslo, Norway.; Axcrona K; Department of Urology, Oslo University Hospital HF, Oslo, Norway.; Department of Urology, Akershus University Hospital HF, Oslo, Norway.; Axcrona U; Department of Pathology, Oslo University Hospital HF, Oslo, Norway.; Bigalke I; Department of Oncology, Oslo University Hospital HF, Oslo, Norway.; BioNTech IMFS GmbH, Idar-Oberstein, Germany.; Brennhovd B; Department of Urology, Oslo University Hospital HF, Oslo, Norway.; Inderberg EM; Department of Oncology, Oslo University Hospital HF, Oslo, Norway.; Hønnåshagen TK; Department of Oncology, Oslo University Hospital HF, Oslo, Norway.; Skoge LJ; Department of Oncology, Oslo University Hospital HF, Oslo, Norway.; Solum G; Department of Oncology, Oslo University Hospital HF, Oslo, Norway.; Saebøe-Larssen S; Department of Oncology, Oslo University Hospital HF, Oslo, Norway.; Josefsen D; Department of Oncology, Oslo University Hospital HF, Oslo, Norway.; Olaussen RW; Department of Oncology, Oslo University Hospital HF, Oslo, Norway.; Aamdal S; Department for Clinical Research, Oslo University Hospital HF, Oslo, Norway.; Skotheim RI; Department of Molecular Oncology, Oslo University Hospital HF, Oslo, Norway.; Myklebust TÅ; Department of Registration, Cancer Registry Norway, Oslo, Norway.; Department of Research and Innovation, Møre and Romsdal Hospital Trust, Ålesund, Norway.; Schendel DJ; Medigene Immunotherapies GmbH, Munich, Germany.; Lilleby W; Department of Oncology, Oslo University Hospital HF, Oslo, Norway.; Dueland S; Department for Clinical Research, Oslo University Hospital HF, Oslo, Norway.; Kvalheim G; Department of Oncology, Oslo University Hospital HF, Oslo, Norway.
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8101368 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0045 (Electronic) Linking ISSN: 02704137 NLM ISO Abbreviation: Prostate Subsets: MEDLINE
Academic Journal
Davari K; Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany.; Holland T; Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany.; Prassmayer L; Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany.; Longinotti G; Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany.; Ganley KP; bluebird bio Inc, Cambridge, Massachusetts, USA.; Pechilis LJ; bluebird bio Inc, Cambridge, Massachusetts, USA.; Diaconu I; ElevateBio, Cambridge, Massachusetts, USA.; Nambiar PR; bluebird bio Inc, Cambridge, Massachusetts, USA.; Magee MS; bluebird bio Inc, Cambridge, Massachusetts, USA.; Schendel DJ; Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany d.schendel@medigene.com.; Sommermeyer D; Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany.; Ellinger C; Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Academic Journal
Lichtenegger FS; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany.; Present address: Roche Innovation Center Munich Penzberg Germany.; Schnorfeil FM; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) Heidelberg Germany.; Present address: Medigene AG Planegg Germany.; Rothe M; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany.; Deiser K; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany.; Altmann T; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany.; Bücklein VL; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany.; Köhnke T; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany.; Augsberger C; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany.; Konstandin NP; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Spiekermann K; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Moosmann A; DZIF Research Group 'Host Control of Viral Latency and Reactivation' (HOCOVLAR) Helmholtz Zentrum München Munich Germany.; Boehm S; Max von Pettenkofer Institute LMU Munich Munich Germany.; Boxberg M; Institute of Pathology Technical University of Munich Munich Germany.; Heemskerk MH; Department of Hematology Leiden University Medical Center Leiden The Netherlands.; Goerlich D; Institute of Biostatistics and Clinical Research University of Muenster Muenster Germany.; Wittmann G; Department of Transfusion Medicine, Cellular Therapeutics and Hemostaseology University Hospital LMU Munich Munich Germany.; Wagner B; Department of Transfusion Medicine, Cellular Therapeutics and Hemostaseology University Hospital LMU Munich Munich Germany.; Hiddemann W; Department of Medicine III University Hospital, LMU Munich Munich Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) Heidelberg Germany.; Schendel DJ; Medigene AG Planegg Germany.; Kvalheim G; Department of Cellular Therapy The Norwegian Radium Hospital Oslo University Hospital Oslo Norway.; Bigalke I; Department of Cellular Therapy The Norwegian Radium Hospital Oslo University Hospital Oslo Norway.; Present address: BioNTech IMFS Idar-Oberstein Germany.; Subklewe M; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) Heidelberg Germany.
Publisher: John Wiley & Sons Australia, Ltd. on behalf of Australasian Society for Immunology Inc Country of Publication: Australia NLM ID: 101638268 Publication Model: eCollection Cited Medium: Print ISSN: 2050-0068 (Print) Linking ISSN: 20500068 NLM ISO Abbreviation: Clin Transl Immunology Subsets: PubMed not MEDLINE
Academic Journal
Issels RD; Department of Medicine III, University Hospital, Munich, Germany.; Lindner LH; Department of Medicine III, University Hospital, Munich, Germany.; von Bergwelt-Baildon M; Department of Medicine III, University Hospital, Munich, Germany.; Lang P; Department of General Pediatrics, Hematology/Oncology, University Children's Hospital, Tuebingenthe, Germany.; Rischpler C; Department of Nuclear Medicine, Technical University Munich, Munich, Germany.; Diem H; Laboratory for Hematological Diagnostics, Gauting, Germany.; Mosetter B; Immunoanalytics Research Group - Tissue Control of Immunocytes & Core Facility, Helmholtz Center, Munich, Germany.; Eckl J; Medigene Company, Martinsried, Germany.; Schendel DJ; Medigene Company, Martinsried, Germany.; Salat C; Medical Center for Hematology and Oncology Munich, Munich, Germany.; Stötzer O; Medical Center for Hematology and Oncology Munich, Munich, Germany.; Burdach S; Department of Pediatrics and Children's Cancer Research Center, Technical University of Munich, Munich, Germany.; von Luettichau-Teichert I; Department of Pediatrics and Children's Cancer Research Center, Technical University of Munich, Munich, Germany.; Handgretinger R; Department of General Pediatrics, Hematology/Oncology, University Children's Hospital, Tuebingenthe, Germany.; Neumann J; Institute of Pathology, LMU, Munich, Germany.; Kirchner T; Institute of Pathology, LMU, Munich, Germany.; Steiger K; Institute of Pathology, Technical University Munich, Munich, Germany.; Boxberg M; Institute of Pathology, Technical University Munich, Munich, Germany.; Mansmann U; Institute of Biostatistics and Epidemiology, LMU, Munich, Germany.; Multhoff G; Radiation Immune-Oncology Group, Center for Translational Cancer Research, Technical University Munich, Munich, Germany.; Noessner E; Immunoanalytics Research Group - Tissue Control of Immunocytes & Core Facility, Helmholtz Center, Munich, Germany.
Publisher: Informa Healthcare Country of Publication: England NLM ID: 8508395 Publication Model: Print Cited Medium: Internet ISSN: 1464-5157 (Electronic) Linking ISSN: 02656736 NLM ISO Abbreviation: Int J Hyperthermia Subsets: MEDLINE
Academic Journal
Mösch A; Department of Bioinformatics, Wissenschaftszentrum Weihenstephan, Technische Universität München, Freising, Germany.; Medigene Immunotherapies GmbH, a subsidiary of Medigene AG, Planegg, Germany.; Raffegerst S; Medigene Immunotherapies GmbH, a subsidiary of Medigene AG, Planegg, Germany.; Weis M; Medigene Immunotherapies GmbH, a subsidiary of Medigene AG, Planegg, Germany.; Schendel DJ; Medigene Immunotherapies GmbH, a subsidiary of Medigene AG, Planegg, Germany.; Frishman D; Department of Bioinformatics, Wissenschaftszentrum Weihenstephan, Technische Universität München, Freising, Germany.
Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101560621 Publication Model: eCollection Cited Medium: Print ISSN: 1664-8021 (Print) Linking ISSN: 16648021 NLM ISO Abbreviation: Front Genet Subsets: PubMed not MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Schendel DJ
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어